Gene therapy holds promise for rare form of color blindness

04/23/2010 | United Press International

U.S. scientists said they were able to re-establish cone function in two dogs with congenital achromatopsia, a rare genetic disorder that causes color blindness, after treating them with recombinant adeno-associated virus-mediated gene therapy. The disease affects about 1 in 50,000 people.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX